85110-06-1

Basic information

• Product Name: 5-Formylimidazole-4-carboxylic acid methyl ester
• Synonyms: 1H-Imidazole-4-carboxylicacid,5-formyl-,methylester(9CI);5-Formylimidazole-4-Carboxylic Acid Methyl Ester;1H-IMIDAZOLE-5-CARBOXYLIC ACID, 4-FORMYL-, METHYL ESTER;4-ForMyl-1H-iMidazole-5-carboxylic acid Methyl ester;Methyl 5-forMyl-1H-iMidazole-4-carboxylate
• CAS NO: 85110-06-1
• Molecular Formula: C₆H₆N₂O₃
• Molecular Weight: 154.12
• Product Categories: GLYCINESCAFFOLD
• Mol File: 85110-06-1.mol

Chemical Properties

• Boiling Point: 433.9 °C at 760 mmHg
• Flash Point: 216.2 °C
• Appearance: /
• Density: 1.394 g/cm³
• Vapor Pressure: 9.85E-08mmHg at 25°C
• Refractive Index: 1.589
• Storage Temp.: 2-8°C
• PKA: 8.67±0.10(Predicted)
• CAS DataBase Reference: 5-Formylimidazole-4-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Formylimidazole-4-carboxylic acid methyl ester(85110-06-1)
• EPA Substance Registry System: 5-Formylimidazole-4-carboxylic acid methyl ester(85110-06-1)

Safety Data

• Hazardous Substances Data: 85110-06-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Biomedical Research:
5-Formylimidazole-4-carboxylic acid methyl ester is used as a key building block for the synthesis of various pharmaceuticals and biologically active compounds. Its versatile chemical structure allows for the development of new drugs with potential therapeutic applications.
Used in Antioxidant and Anti-inflammatory Applications:
5-FICA methyl ester is utilized as an antioxidant and anti-inflammatory agent due to its demonstrated properties in medicinal chemistry research. These properties make it a promising candidate for the treatment of conditions associated with oxidative stress and inflammation.
Used in Disease and Disorder Treatment:
The derivatives of 5-Formylimidazole-4-carboxylic acid methyl ester are explored for their potential use in the treatment of various diseases and disorders. 5-Formylimidazole-4-carboxylic acid methyl ester's unique structure and pharmacological properties offer opportunities for the development of novel therapeutic agents.
Used in Antimicrobial Agents Development:
5-FICA methyl ester and its derivatives have been investigated for their potential as antimicrobial agents. 5-Formylimidazole-4-carboxylic acid methyl ester's ability to combat microbial infections makes it a valuable asset in the development of new antimicrobial drugs, particularly in the face of increasing antibiotic resistance.
Used in Medicinal Chemistry Research:
5-Formylimidazole-4-carboxylic acid methyl ester serves as a subject of interest in medicinal chemistry research, where its properties and potential applications are further studied and understood. This research contributes to the advancement of pharmaceutical and biomedical sciences.

InChI:InChI=1/C6H6N2O3/c1-11-6(10)5-4(2-9)7-3-8-5/h2-3H,1H3,(H,7,8)

Upstream product

• 85109-99-5 methyl 5-diethoxymethylimidazole-4-carboxylate 
• 141849-12-9 Methyl 1-<(benzyloxy)methyl>-5-(1,3-dioxolan-2-yl)-imidazole-4-carboxylate 
• 141849-11-8 Methyl 1-<(benzyloxy)methyl>-5-(1,3-dioxolan-2-yl)-2-(phenylthio)imidazole-4-carboxylate 

Downstream Products

• 28682-94-2 (1H)-Imidazo<4,5-d>pyriddazine-4(5H)-one 
• 1094091-46-9 3-bromo-7-(tert-butoxycarbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1-carboxylic acid 

Relevant articles and documents

INHIBITORS OF MUTANT ISOCITRATE DEHYDROGENASES AND COMPOSITIONS AND METHODS THEREOF

The invention provides novel chemical compounds useful for treating cancer, or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.

Substituted Spiroamide Compounds

Substituted spiroamide compounds corresponding to formula (I): wherein A, B, Q1, Q2, Q3, Q4, R1, R8, R9a, R9b, R12, R13, R200 and R210 have defined meanings, processes for their preparation, pharmaceutical compositions containing such compounds, and the use of such compounds for treating or inhibiting pain or other conditions mediated at least in part by the bradykinin 1 receptor (B1R).

SUBSTITUTED IMIDAZOHETEROCYCLES

The present invention provides substituted imidazoheterocyclic compounds having the structure of formula I Also provided are pharmaceutically acceptable salts, acid salts, hydrates, solvates and stereoisomers of the compounds of formula I. The compounds are useful as modulators of cannabinoid receptors and for the prophylaxis and treatment of cannabinoid receptor-associated diseases and conditions, such as pain, inflammation and pruritis.

Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor α (TNF-α) production: Selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3- carbonitriles

Tumor progression loci-2 (Tpl2) (Cot/MAP3K8) is a serine/threonine kinase in the MAP3K family directly upstream of MEK. Recent studies using Tpl2 knockout mice have indicated an important role for Tpl2 in the lipopolysaccharide (LPS) induced production of